Precigen (PGEN) Competitors

Avid Bioservices (NASDAQ:CDMO) and Precigen (NASDAQ:PGEN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Do insiders and institutionals hold more shares of CDMO or PGEN?

97.2% of Avid Bioservices shares are owned by institutional investors. Comparatively, 33.5% of Precigen shares are owned by institutional investors. 3.1% of Avid Bioservices shares are owned by insiders. Comparatively, 44.9% of Precigen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has preferable earnings and valuation, CDMO or PGEN?

Precigen has lower revenue, but higher earnings than Avid Bioservices. Avid Bioservices is trading at a lower price-to-earnings ratio than Precigen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avid Bioservices	$150.45M	5.25	-$140.75M	-$2.39	-5.17
Precigen	$3.96M	51.01	-$95.90M	-$0.55	-1.25

Does the MarketBeat Community believe in CDMO or PGEN?

Precigen received 64 more outperform votes than Avid Bioservices when rated by MarketBeat users. Likewise, 67.29% of users gave Precigen an outperform vote while only 65.95% of users gave Avid Bioservices an outperform vote.

Company	Underperform	Outperform
Avid Bioservices	Outperform Votes 370 65.95%	Underperform Votes 191 34.05%
Precigen	Outperform Votes 434 67.29%	Underperform Votes 211 32.71%

Does the media prefer CDMO or PGEN?

In the previous week, Avid Bioservices had 3 more articles in the media than Precigen. MarketBeat recorded 4 mentions for Avid Bioservices and 1 mentions for Precigen. Avid Bioservices' average media sentiment score of 0.15 beat Precigen's score of -1.14 indicating that Avid Bioservices is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avid Bioservices	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Precigen	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

Is CDMO or PGEN more profitable?

Avid Bioservices has a net margin of -101.07% compared to Precigen's net margin of -3,521.68%. Avid Bioservices' return on equity of -33.18% beat Precigen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avid Bioservices	-101.07%	-33.18%	-8.45%
Precigen	-3,521.68%	-123.06%	-87.33%

Do analysts rate CDMO or PGEN?

Avid Bioservices presently has a consensus price target of $12.25, indicating a potential downside of 0.89%. Precigen has a consensus price target of $7.00, indicating a potential upside of 914.20%. Given Precigen's stronger consensus rating and higher possible upside, analysts clearly believe Precigen is more favorable than Avid Bioservices.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avid Bioservices	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Precigen	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Which has more risk and volatility, CDMO or PGEN?

Avid Bioservices has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Precigen has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500.

Summary

Precigen beats Avid Bioservices on 11 of the 18 factors compared between the two stocks.